Literature DB >> 7609514

The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension.

G Bond1, C Dal Palú, L Hansson, B Magnani, G Mancia, A Neiss, K H Rahn, J L Reid, J L Rodicio, M Safar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7609514

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  3 in total

1.  Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure.

Authors:  Günay Yetik Anacak; Levent Ustünes; Ozlem Yilmaz Dilsiz; Adviye Ergul
Journal:  Vascul Pharmacol       Date:  2010-08-12       Impact factor: 5.773

Review 2.  Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.

Authors:  C R Lee; H M Bryson
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

3.  Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.

Authors:  Emma Copland; Dexter Canoy; Milad Nazarzadeh; Zeinab Bidel; Rema Ramakrishnan; Mark Woodward; John Chalmers; Koon K Teo; Carl J Pepine; Barry R Davis; Sverre Kjeldsen; Johan Sundström; Kazem Rahimi
Journal:  Lancet Oncol       Date:  2021-04       Impact factor: 41.316
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.